|
PDGFC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.039700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.461780E-03 |
| Normal-vs-Stage2 |
9.742300E-02 |
| Normal-vs-Stage3 |
2.253800E-01 |
| Normal-vs-Stage4 |
1.204220E-01 |
| Stage1-vs-Stage2 |
9.247800E-01 |
| Stage1-vs-Stage3 |
4.975800E-01 |
| Stage1-vs-Stage4 |
8.093000E-01 |
| Stage2-vs-Stage3 |
7.034000E-01 |
| Stage2-vs-Stage4 |
7.926000E-01 |
| Stage3-vs-Stage4 |
5.825000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.172700E-04 |
| Normal-vs-AfricanAmerican |
4.783500E-03 |
| Normal-vs-Asian |
3.043800E-02 |
| Caucasian-vs-AfricanAmerican |
7.859000E-01 |
| Caucasian-vs-Asian |
5.797900E-02 |
| AfricanAmerican-vs-Asian |
1.004160E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.772700E-04 |
| Normal-vs-Female |
2.117400E-03 |
| Male-vs-Female |
7.290400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.423700E-02 |
| Normal-vs-Extreme_Weight |
6.543700E-03 |
| Normal-vs-Obese |
5.994300E-04 |
| Normal-vs-Extreme_Obese |
1.784170E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.757800E-01 |
| Normal_Weight-vs-Obese |
8.230000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.546600E-01 |
| Extreme_Weight-vs-Obese |
2.421800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.323800E-01 |
| Obese-vs-Extreme_Obese |
3.845600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.460100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.647800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.580060E-02 |
| Normal-vs-Age(81-100Yrs) |
7.819900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.891800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.555000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.987800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.346400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.298600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.61169999999867E-05 |
| Normal-VS-Type2 PRCC |
1.727840E-01 |
| Normal-VS-KIRP CIMP |
1.150450E-01 |
| Normal-VS-Unclassified PRCC |
1.393510E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.843730E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.410000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.268200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.043610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.403800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.727400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.578200E-01 |
| Normal-vs-N1 |
9.903900E-02 |
| Normal-vs-N2 |
2.369200E-01 |
| N0-vs-N1 |
1.384170E-01 |
| N0-vs-N2 |
2.627600E-01 |
| N1-vs-N2 |
6.915000E-01 |
|
|
